FDA warns Beauty of Aztlan it sells unapproved, misbranded injectable botulinum toxin drugs online to U.S. consumers.
What happened
FDA reviewed the website www.beautyofaztlan.squarespace.com and found it offering injectable botulinum toxin type A products, "Botulax 100units" and "Innotox 50units", for sale to U.S. consumers. The site described the products' uses as "Correction of blepharospasm" and "Hyperhidrosis (increased sweating)", which FDA says shows the products are drugs intended for human use. FDA says no approved drug application exists for these products and they were offered without a prescription.
What FDA found
The company sells botulinum toxin drugs that FDA has never approved for the U.S. market.
Section 505(a) of the FD&C Act [21 U.S.C. § 355(a)]; section 301(d) [21 U.S.C. § 331(d)]The product labeling does not give adequate directions for safe use by an ordinary person.
Section 502(f)(1) of the FD&C Act [21 U.S.C. § 352(f)(1)]; 21 CFR 201.5; 21 CFR 201.115(a)The company offers prescription drugs without requiring a prescription from a licensed practitioner.
Section 503(b)(1) of the FD&C Act [21 U.S.C. § 353(b)(1)]Offering these drugs without a prescription results in misbranded drugs being held for sale.
Section 301(k) of the FD&C Act [21 U.S.C. § 331(k)]The company causes misbranded drugs to be brought into interstate commerce.
Section 301(a) of the FD&C Act [21 U.S.C. § 331(a)]
What FDA wants
FDA asks the company to stop offering unapproved and misbranded drugs for sale to U.S. consumers and to review its websites, labels and promotional materials. The company must reply in writing within 15 working days describing the steps taken and how it will prevent recurrence.
Who should pay attention
- med spas and aesthetic clinics that buy botulinum toxin online
- consumers buying cosmetic injectables from websites
- distributors and importers of unapproved botulinum toxin brands
This is a summary. Read the original letter on fda.gov.